Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
PONATINIB 15MG TAB is a federal award for 260-Network Contract Office 20 (36C260) held by Millennium Pharmaceuticals, Inc. Estimated value $116K ($23K obligated). Current period of performance ends Apr 4, 2021. Last award drew 1 bidder. Place of performance: CAMBRIDGE MA.
Recompete timing
PublicCurrent PoP ended Apr 4, 2021 (1966 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26021F0164?
36C26021F0164 (Ponatinib 15mg TAB) is a 260-Network Contract Office 20 (36C260) award with a potential value of $116K, currently held by Millennium Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C260-21-F-0164?
36C260-21-F-0164 is the dashed form of PIID 36C26021F0164 (Ponatinib 15mg TAB), held by Millennium Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26021F0164?
260-Network Contract Office 20 (36C260) awarded 36C26021F0164 to Millennium Pharmaceuticals, Inc (potential $116K).
Who is the incumbent on 36C26021F0164?
Millennium Pharmaceuticals, Inc is the incumbent. The current period of performance ends Apr 4, 2021.
When does Millennium Pharmaceuticals, Inc’s 36C26021F0164 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 4, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.